pCPA

All the posts published.

Biosimilar Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 8, 2017
-
Market Access News, Publications
-
Posted by MORSE Team
Read More →
Read More →

pCPA Update as of June 30, 2017

July 10, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Introducing the MORSE WIRE – Live market access news and trends at your finger tips

June 22, 2017
-
Market Access News, What's New
-
Posted by MORSE Team
Read More →
Read More →

pCPA Update as of May 31, 2017

June 14, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Federal Health Minister, Hon. Jane Philpott, Announces PMPRB Consultations

May 16, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

pCPA Update as of April 30, 2017

May 12, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

pCPA Update as of March 31, 2017

April 12, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

pCPA Update as of February 28, 2017

March 16, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

The pan-Canadian Cancer Drug Funding Sustainability Initiative

March 8, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Canada Attempts Biosimilar Balancing Act

March 2, 2017
-
Publications
-
Posted by MORSE Team
Read More →
Read More →

Perspective on the pCPA Hepatitis C Negotiation

February 24, 2017
-
Market Access News
-
No comments
-
Posted by MORSE Team
Read More →
Read More →

pCPA Update as of January 31, 2017

February 9, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

MORSE Perspective on pCPA Update as of December 31 2016

February 3, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →
pCPA - Info and details on - Page 7 of 7 - MORSE Consulting Inc.